Patent applications published 13 October 2010
Selected patent applications from the weekly European Patents Bulletin
- Novel formulation
Glaxo Group 2237662*
- (Het) aryl-p-quinone derivatives for treatment of mitochondrial diseases
Edison Pharmaceuticals 2237664*
- HCV protease inhibitors and uses thereof
Avila Therapeutics 2237666*
- HCV protease inhibitors and uses thereof
Avila Therapeutics 2237667*
- Phenylephrine pharmaceutical formulations and compsns for transmucosal absorption
Schering-Plough Healthcare Products 2237767*
- Formulations of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridine-2-yl)benzoic acid
Vertex Pharmaceuticals Inc 2237768*
- Biocompatible protein particles, particle devices and methods thereof
Gel-Del Technologies 2237770*
- Pharmaceutical compsns comprising granules of purified microbial lipase and methods of preventing or treating digestive disorders
Abbott Products 2237771*
- Method and multilayered device for controlled topical delivery of therapeutic agents to the skin
Newmedical Technologies 2237772*
- Compsns and methods for improving cardiovascular health
HealthSpan Solutions 2237776*
- Compsns and methods for treating neurodegenerative diseases
Marine Bio 2237777*
- Methods of treating hematologic cancers using PNP inhibitors such as forodesine in combination with alkylating agents or anti-CD20 agents
Biocryst Pharmaceuticals 2237778*
- Benzothiazole and benzoxazole derivatives and methods of use
Abbott Laboratories 2237779*
- Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives
Meda 2237780*
- Pharmaceutical compsn comprising tesofensine or its analogue and an anti-obesity agent
NeuroSearch 2237781*
- Use of tetrahydropyrimidines
Bitop 2237782*
- Method of optimising the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib
Novartis 2237783*
- Activators of executioner procaspases 2, 6 and 7
The Regents of the University of California 2237784*
- Triarylmethane analogues and their use in treating cancers
Emory University 2237785*
- Use of inhibitors of connexin43 for treatment of fibrotic conditions
Coda Therapeutics 2237786*
- Decoy influenza therapies
Massachusetts Institute of Technology 2237787*
- Aerosolised nitrite and nitric oxide-donating compounds and uses thereof
Aires Pharmaceuticals 2237788*
- Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
Ethicon 2237789*
- Attenuated oncolytic paramyxoviruses encoding avian cytokines
Bayer Schering Pharma 2237790*
- Means for smoking cessation
Ds-pharma 2237791*
- Anti-C35 antibody combination therapies and methods
Vaccinex 2237792*
- Inhibitors of cathepsin B
Virobay 2237793*
- Chimeric HIV fusion proteins as vaccines
Healthbanks USA; Healthbanks Biotech; Liao, Chao-Wei; Chang, Hsiu-Kang 2237794*
- Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
Coda Therapeutics 2237795*
- Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
Coda Therapeutics 2237796*
- Antibody targeting through a modular recognition domain
The Scripps Research Institute 2237797*
- Prodrug comprising a self-cleavable linker
Ascendis Pharma 2237799*
- Biodegradable contrast agents
Iopharma Technologies 2237800*
- MR imaging agent or medium comprising hyperpolarised 13C alanine and methods of imaging wherein such an imaging medium is used
GE Healthcare 2237801*
- Method to produce hyperpolarised amino acids and aminosulphonic agents
GE Healthcare 2237802*
- Treatment and prophylaxis of amyloidosis
Elan Pharmaceuticals 2237803*
- Method for sterilisation of chemically activated solid support materials
GE Healthcare Bio-Sciences 2237804*
- Imiqimod formulation
Dow Pharmaceutical 2237805*
- Pulverised fibrin clots and pharmaceutical compsns containing them
Metamorefix 2237806*
- Hydrogel compsns and uses thereof
Zimmer 2237807*
- Open-pore biocompatible surface coating for an implant, method for producing the same, and use thereof
Smith & Nephew Orthopaedics 2237808*
- Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor agonist; and pharmaceutical compsns containing the same
Amorepacific Corp 2238105*
- Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative
Boehringer Ingelheim International 2238107*
- Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compsns containing same
Boehringer Ingelheim International 2238108*
- 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist against biological activity
Allergan 2238109*
- 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors
Sanofi-Aventis 2238111*
- 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of secretase (BACE)
Janssen Pharmaceutica 2238112*
- N-[3-bromo-2-chloro-4-(4,5-dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulphoamide as alpha-1A adrenergic partial agonist for the treatment of incontinence
F Hoffmann-La Roche 2238113*
- Novel imdazolinylmethyl aryl sulphonamides
F Hoffmann-La Roche 2238114*
- Novel imdazolinylmethyl aryl sulphonamides
F Hoffmann-La Roche 2238115*
- Novel imdazolinylmethyl aryl sulphonamides
F Hoffmann-La Roche 2238116*
- 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
NeuroSearch 2238117*
- Method of synthesis of bosentan, its polymorphic forms and its salts
Cipla 2238118*
- Quinazolines and related heterocyclic compounds, and their therapeutic use
Vereniging voor Christelijk Hoger Onderwijs 2238119*
- Improved process for making triphenylboron-pyridine compound
Invista Technologies 2238120*
- UVA filter based on ascorbic acid derivatives
Merck Patent 2238121*
- Preparation of sulfamide derivatives
Janssen Pharmaceutica 2238122*
- Addition reaction to fluoroallylfluorosulphate
Solvay Solexis 2238123*
- A process for the production of cyclic diesters of alpha-hydroxyacids
Ktanton 2238124*
- Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
NeuroSearch 2238125*
- Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
Sanofi-Aventis 2238126*
- Pyrazole-carboxamide derivatives as P2Y12 antagonists
Sanofi-Aventis 2238127*